Breast Cancer Test, Breast Cancer Awareness - Agendia & MammaPrint

2 Views

07/10/23

Visit http://www.Agendia.com to learn more about MammaPrint, the only FDA approved breast cancer recurrence test. Background information about Agendia and innovative technology used in developing MammaPrint and other ground-breaking

diagnostic tests. The MammaPrint breast cancer recurrence test determines whether an early breast cancer patient is at "low risk" or "high risk" of metastasis, or breast cancer recurrence. The results from MammaPrint help personalize and determine the best breast cancer therapy for each individual patient, thereby enabling patients to avoid harmful side-effects of unnecessary treatments.